Human iPSC-Derived Cerebral Organoid Differentiation Kit
组分(Materials Provided)
![1.jpg 1.jpg](/SupplyImg1/2024-06-20/6385447353457306351278251.jpg)
产品描述(Product Details)
Human iPSC-Derived Cerebral Organoid Differentiation Kit (Ca. No. RIPO-BWM001K) allows hESC or hiPSC to differentiate into cerebral organoids. Cerebral organoids are three-dimensional in vitro models with a cellular composition and structural organization that is representative to the human cerebral regions. This kit can produce 96 cerebral organoids in three steps. Differentiation was carried out by forming EBs from PSC at an ultra-low attachment U shape 96 well plate, and then changing the medium according to the instructions. Organoids generated using Human iPSC-Derived Cerebral Organoid Differentiation Kit (Ca. No. RIPO-BWM001K) feature various types of neurons (including TH postive neurons) and glia cells (including OLIG2 and IBA1 positive cells). These cerebral organoids show spontaneous electrophysiological activity and response to a-syn PFFs induced toxicity, representing the functionality of the organoids.
产品特征(Product Specification)
The basic medium of this kit is a serum-free, well-defined medium with minimal batch variation to which differentiation factors are added. This medium does not contain antibiotics, the addition of which may affect organoid differentiation.
存储(Storage)
The unopened Box A is stable for 12 months from the date of manufacture if stored under 2-8°C.
The unopened Box B is stable for 12 months from the date of manufacture if stored under -20°C.
The opened kit should be stored according to components table.
![2.jpg 2.jpg](/SupplyImg1/2024-06-20/6385447354691992787272618.jpg)
![3.jpg 3.jpg](/SupplyImg1/2024-06-20/6385447355134815875789964.jpg)
![4.jpg 4.jpg](/SupplyImg1/2024-06-20/6385447355591556898822168.jpg)
![5.jpg 5.jpg](/SupplyImg1/2024-06-20/6385447355907036146496473.jpg)
![6.jpg 6.jpg](/SupplyImg1/2024-06-20/6385447356229922894669767.jpg)
关键字: 器官分化试剂盒;细胞分化试剂盒;Organoid Kits;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。